Skip to main content

Table 1 SRI's used by subjects for failed treatment trial prior to inclusion in the study.

From: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Drug N Mean maximum tolerated dose (mg/day) Median daily dose (mg/day) Range
Fluoxetine 13 60 60 60
Citalopram 10 61 60 10
Paroxetine 4 65 60 20
Fluvoxamine 10 290 300 100
Sertraline 1 200 200 0
Clomipramine 2 250 250 0